federal_register: 2015-28804

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2015-28804 Guidance on Qualification of Biomarker-Galactomannan in Studies of Treatments of Invasive Aspergillosis; Guidance for Industry; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Guidance on Qualification of Biomarker--Galactomannan in Studies of Treatments of Invasive Aspergillosis." This guidance provides a qualified context of use (COU) for Galactomannan detection in serum and/or bronchoalveolar lavage (BAL) fluid as the sole microbiological criterion to classify patients as having probable invasive Aspergillosis (IA) for enrollment in clinical trials. This guidance also describes the experimental conditions and constraints for which this biomarker is qualified through the CDER Biomarker Qualification Program. This biomarker can be used by drug developers for the qualified COU in submissions of investigational new drug applications (INDs), new drug applications (NDAs), and biologics license applications (BLAs) without the relevant CDER review group reconsidering and reconfirming the suitability of the biomarker. 2015-11-13 2015 11 https://www.federalregister.gov/documents/2015/11/13/2015-28804/guidance-on-qualification-of-biomarker-galactomannan-in-studies-of-treatments-of-invasive https://www.govinfo.gov/content/pkg/FR-2015-11-13/pdf/2015-28804.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Guidance on Qualification of Biomarker--Galactomannan in Studies of Treatments of Invasive Aspergillosis." This guidance provides a qualified...

Links from other tables